<p>The Nimhans in collaboration with the Institute of Bio-informatics (IOB) on Tuesday launched a laboratory, dedicated to Bio-informatics and Proteomics, to help scientists understand the functioning of brain cells better. <br /><br /></p>.<p>The new advanced mass spectrometer facility for clinical proteomics will help get an insight into the health and diseases that the brain cells might process. <br /><br />Inaugurating the Advanced Mass Spectrometer Facility, P Satish Chandra, director, Nimhans, said, “The collaboration with IOB is to utilise genomic and proteomic platforms for molecular profiling of neuro infections and neurological diseases.”<br /><br />He added that Nimhans had also produced a high resolution 'Orbitrap Fusion Tribrid Mass Spectrometer' at the facility to enable mapping of human brain proteome during the development of neurological diseases.<br /><br />The state-of-art machine with high resolving power cost Rs 6.5 crore and the equipment was installed in a record time of six days to bring it to functionality. <br /><br />The team has planned to study neurological and psychiatric disorders, neuro infections and brain tumours. In addition, the Nimhans-IOB team proposes to establish a map of proteome and protein modifications in different parts of the human brain during normal development, from foetal to infant, adolescent and adult brain.<br /><br />To generate proteomic data on several human tissues, Nimhans has also joined hands with Johns Hopkins University. <br /><br />“This facility will provide an insight into the protein function in brain cells and pave the way for better treatment,” said S R Patil, Minister for Planning and Statistics, IT, BT, Science and technology.<br /></p>
<p>The Nimhans in collaboration with the Institute of Bio-informatics (IOB) on Tuesday launched a laboratory, dedicated to Bio-informatics and Proteomics, to help scientists understand the functioning of brain cells better. <br /><br /></p>.<p>The new advanced mass spectrometer facility for clinical proteomics will help get an insight into the health and diseases that the brain cells might process. <br /><br />Inaugurating the Advanced Mass Spectrometer Facility, P Satish Chandra, director, Nimhans, said, “The collaboration with IOB is to utilise genomic and proteomic platforms for molecular profiling of neuro infections and neurological diseases.”<br /><br />He added that Nimhans had also produced a high resolution 'Orbitrap Fusion Tribrid Mass Spectrometer' at the facility to enable mapping of human brain proteome during the development of neurological diseases.<br /><br />The state-of-art machine with high resolving power cost Rs 6.5 crore and the equipment was installed in a record time of six days to bring it to functionality. <br /><br />The team has planned to study neurological and psychiatric disorders, neuro infections and brain tumours. In addition, the Nimhans-IOB team proposes to establish a map of proteome and protein modifications in different parts of the human brain during normal development, from foetal to infant, adolescent and adult brain.<br /><br />To generate proteomic data on several human tissues, Nimhans has also joined hands with Johns Hopkins University. <br /><br />“This facility will provide an insight into the protein function in brain cells and pave the way for better treatment,” said S R Patil, Minister for Planning and Statistics, IT, BT, Science and technology.<br /></p>
